Related references
Note: Only part of the references are listed.Evaluation of a new visual uptake scoring scale for 18F-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesions
Jean-Mathieu Beauregard et al.
NUCLEAR MEDICINE COMMUNICATIONS (2013)
The prognostic significance of hypoxia inducing factor 1-α in oropharyngeal cancer in relation to human papillomavirus status
Angela Hong et al.
ORAL ONCOLOGY (2013)
Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer
Kasper Toustrup et al.
CANCER RESEARCH (2011)
More Lessons Learned From the Suffocation of Hypoxia
K. Kian Ang
JOURNAL OF CLINICAL ONCOLOGY (2010)
p16 Expression As a Predictive Biomarker of Hypoxic Cell-Sensitizing Agents in Oropharyngeal Cancer
Christine H. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
Danny Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
Danny Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
Lester J. Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
HPV-associated head and neck cancer: a virus-related cancer epidemic
Shanthi Marur et al.
LANCET ONCOLOGY (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
Pernille Lassen et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients
Kathleen Settle et al.
CANCER PREVENTION RESEARCH (2009)
THE RELATIONSHIP BETWEEN HUMAN PAPILLOMAVIRUS STATUS AND OTHER MOLECULAR PROGNOSTIC MARKERS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS
Christina S. Kong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck
Pernille Lassen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Comparative Prognostic Value of HPV16 E6 mRNA Compared With In Situ Hybridization for Human Oropharyngeal Squamous Carcinoma
Wei Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
Carole Fakhry et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers
Maura L. Gillison et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Hypoxic radiosensitization: Adored and ignored
Jens Overgaard
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tumor microenvironment in head and neck squamous cell carcinomas: Predictive value and clinical relevance of hypoxic markers. A review
Ilse J. Hoogsteen et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
Case-control study of human papillomavirus and oropharyngeal cancer
Gypsyamber D'Souza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Hypoxia in head and neck cancer: Studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins
Danny Rischin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine:: A substudy of Trans-Tasman Radiation Oncology Group study 98.02
D Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent
RJ Hicks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study
M Nordsmark et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: A randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)
D Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO):: A comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors
D Sorger et al.
NUCLEAR MEDICINE AND BIOLOGY (2003)
Share Paper
